These data suggest that immunotherapy may result in tumor cell chemokine secretion into the parenchyma rather than into the ductal space, thereby orchestrating the intratumoral migration patterns of Cxcr3 + cells within the stroma. The gene discussed is CXCR3; the disease is neoplasm.